Amarox Limited, the European subsidiary of Hetero – one of India's leading generics companies– has acquired Tarbis Farma, the generic medication division of the Catalan pharmaceutical company Ferrer.

Both companies have reached an agreement whereby Tarbis Farma will provide Amarox Limited with the required commercial infrastructure, product portfolio, workforce and an entry into the generics sector in Spain, and will also serve to reinforce its position in the European market.

For its part, with this move Ferrer guarantees the future viability of Tarbis and of the people associated with it thanks to Hetero's international commitment to the generics market.

Hetero, for whom this represents its entry into Spain, is one of the largest generics manufacturers in India and a world leader in antiretroviral drugs.

According to EFE, Mario Rovirosa, Ferrer's CEO, remarked: “We are sure that the brand will be reinforced by Hetero's international commitment to the generics market”.